Residual Neuromuscular Block: Clinical Trials

2 trials for Residual Neuromuscular Block, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Unknown 1

Follow Residual Neuromuscular Block: new trials by email Literature Review of Residual Neuromuscular Block trials Research Report on Residual Neuromuscular Block

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function
Sugammadex, Neostigmine - Residual Neuromuscular Block
Not applicableRecruitingShanghai Pulmonary Hospital, Shanghai, China2402025-12-302026-06-22
Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
Neuromuscular monitoring, reverse of NMB with sugammadex, reverse of NMB with Sugammadex and neostigmin low dose - Residual Neuromuscular Block, Neuromuscular Blockade Monitoring
Not applicableUnknownAnkara City Hospital Bilkent902022-02-012022-02-08

Narrower conditions

Delayed Emergence from Anesthesia (2)  ·  Postoperative Complications (1)  ·  Postoperative Nausea and Vomiting (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Nausea (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)  ·  Vomiting (1)

Interventions

Sugammadex (2)  ·  Neostigmine (1)  ·  Neuromuscular Monitoring (1)

Sponsors

Ankara City Hospital Bilkent (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (1)  ·  Turkey (Türkiye) (1)

Top investigators

Xin Lv, PhD (1)

Results publications

PMID 39287249